Alvotech Key Fundamental And Technical Indicators

ALVO Stock  USD 3.57  0.07  2.00%   
For Alvotech, the ratios that turn raw financials into comparable signals are assembled. Alvotech has a profit margin of 4.74%. The current ratio is 0.86, showing the ability to cover short-term obligations. From the most recent analysis, Alvotech posts the 14-period RSI reading of 44, between the standard 30 and 50 reference levels. The current RSI level remains above 30 and below 50 on standard interpretation bands.
Momentum
OversoldOverbought
44 · Sell Extended
As of the 7th of May, Alvotech reports 3.57 per share in the latest quote. Technical drivers report Standard Deviation of 3.68, risk adjusted performance of -0.13, and Mean Deviation of 2.92. Price momentum and volatility relationships form the basis of the analysis. Cross-sectional analysis places indicator values in market context.
Alvotech discloses its performance through quarterly and annual statements used to model future cash flows. Performance benchmarked against historical norms is reflected in the key metrics below:
 Gross Profit
353.35 million
 Profit Margin
5.0%
 Market Capitalization
1.11 billion
 Enterprise Value Revenue
4.05
 Revenue
588.9 million
The one hundred twenty fundamental trends available for Alvotech cover valuation, profitability, and capital structure dimensions. Evaluating Alvotech's most recent numbers in the context of performance from 2010 to 2026 helps distinguish cyclical fluctuations from structural shifts. Based on figures reported as of December 31, 2025, Market Cap remains stable near $3.19 billion. Equity Screeners provides expanded screening access beyond individual equity pages. The screening framework complements this analysis with cross-instrument context.

Balance Sheet Accounts

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding200.87 million279.19 million216 M
High Variability
Total Assets$1.02 billion$1.49 billion666.1 M
Moderate Growth
Short and Long Term Debt Total$1.05 billion$1.45 billion796.3 M
Moderate Growth
Other Current Liabilities$72.63 million$126.87 million45.8 M
Moderate Growth
Total Current Liabilities$199.56 million$304.08 million105.8 M
Moderate Growth
Other Liabilities$313.63 million$400.99 million529.4 M
Moderate Decline
Property Plant And Equipment Net$325.07 million$356.4 million227.5 M
Moderate Growth
Current Deferred Revenue$34.31 million$18.38 million20.6 M
Moderate Growth
Net Debt$984.36 million$1.28 billion753.2 M
Moderate Growth
Accounts Payable$66.65 million$126.12 million32.3 M
Moderate Growth
Cash$180.98 million$172.36 million49.9 M
Moderate Growth
Non Current Assets Total$714.79 million$913.08 million499.8 M
Moderate Growth
Non Current Assets Other$283.3 million$269.81 million125.1 M
High Variability
Other Assets$206.16 million$280.31 million169.7 M
Moderate Growth
Long Term Debt$903.53 million$1.26 billion675.6 M
Moderate Growth
Cash And Short Term Investments$180.98 million$172.36 million49.9 M
Moderate Growth
Net Receivables$103.96 million$69.74 million59 M
Moderate Growth
Good Will$9.82 million$12.84 million12.8 M
Moderate Decline
Liabilities And Stockholders Equity$1.02 billion$1.49 billion666.1 M
Moderate Growth
Non Current Liabilities Total$1.41 billion$1.47 billion1.3 B
Moderate Variation
Capital Lease Obligations$120.75 million$150.08 million109.9 M
Moderate Variation
Inventory$231.06 million$220.05 million51.2 M
Moderate Growth
Other Current Assets$117.46 million$111.86 million25.6 M
Moderate Growth
Other Stockholder Equity$1.39 billion$2.11 billion624.9 M
Moderate Growth
Total Liabilities$1.61 billion$1.77 billion1.4 B
Moderate Variation
Property, Plant and Equipment (Gross)$411.87 million$599.21 million280.5 M
Moderate Growth
Short and Long Term Debt$24.35 million$36.92 million10.7 M
Moderate Growth
Total Current Assets$304.44 million$574.01 million166.3 M
Moderate Growth
Accumulated Other Comprehensive Income$20.52 million$16.68 million10.7 M
Moderate Growth
Capital Stock$1.9 million$2.93 million764.6 K
Moderate Growth
Short Term Debt$33.37 million$49 million17.4 M
Moderate Growth
Intangible Assets$85.93 million$81.83 million19.1 M
Moderate Growth
Common Stock$1.9 million$2.93 million764.6 K
Moderate Growth
Property Plant Equipment$238.48 million$308.31 million206.1 M
Moderate Growth

Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income$208.42 million$198.49 million25.6 M
Moderate Growth
Depreciation And Amortization$25.61 million$37.85 million18.8 M
Moderate Growth
Interest Expense$131.88 million$149.19 million107.8 M
Moderate Growth
Selling General Administrative$94.88 million$90.95 million66.8 M
Moderate Growth
Total Revenue$615.64 million$586.32 million134.6 M
Moderate Growth
Other Operating Expenses$373 million$508.11 million211 M
Consistent Growth
Research Development$185.68 million$184.19 million131 M
Consistent Growth
Total Operating Expenses$271.52 million$272.56 million167 M
Moderate Growth
Reconciled Depreciation$25.61 million$37.85 million18.8 M
Moderate Growth

Cash Flow Statement Items

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings$149.97 million$197.69 million110.3 M
Moderate Growth
Begin Period Cash Flow$34.05 million$51.43 million47.2 M
High Variability
Depreciation$25.61 million$37.85 million18.8 M
Moderate Growth
Capital Expenditures$43.62 million$64.47 million23.2 M
Consistent Growth
Issuance Of Capital Stock$116.25 million$82.48 million66.6 M
Moderate Growth
Total Cash From Financing Activities$270.44 million$270.83 million178.7 M
Moderate Growth
End Period Cash Flow$180.98 million$172.36 million70.9 M
High Variability
Change To Liabilities$34.89 million$41.21 million32.6 M
Moderate Growth
Dividends Paid$147.81 million$166.28 million181.5 M
Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.32x2.44x54.9005
Consistent Decline
Days Sales Outstanding41.2443.41204
High Variability
Stock Based Compensation To Revenue0.03x0.03x0.1109
High Variability
Capex To Depreciation$1.3$1.71.0365
Moderate Growth
EV To Sales4.39x4.62x16.4111
High Variability
Inventory Turnover1.531.071.0511
Moderate Growth
Days Of Inventory On Hand321.41340.98375
Moderate Decline
Payables Turnover1.581.871.4791
Moderate Growth
Sales General And Administrative To Revenue0.15x0.16x1.2863
High Variability
Research And Ddevelopement To Revenue0.3x0.31x2.5177
Moderate Decline
Capex To Revenue0.1x0.11x0.3078
High Variability
Cash Per Share0.510.620.7895
Moderate Decline
Days Payables Outstanding217.4195.43257
Moderate Decline
Intangibles To Total Assets$0.04$0.060.0422
Moderate Variation
Current Ratio1.221.891.6029
Moderate Variation
Receivables Turnover8.838.412.6002
High Variability
Capex Per Share0.410.230.1953
High Variability
Average Receivables$34.8 million$39.15 million42.7 M
Stable
Revenue Per Share2.212.10.6811
Moderate Growth
Interest-Bearing Debt Per Share5.445.7218.7627
Moderate Decline
Debt To Assets1.17x0.97x1.2818
Moderate Decline
Operating Cycle$370.41$384.39292
Moderate Growth
Days Of Payables Outstanding217.4195.43257
Moderate Decline
Quick Ratio0.861.161.3154
Moderate Decline
Net Income Per EBT$0.19$0.20.8544
Moderate Decline
Cash Ratio0.370.570.5081
Moderate Decline
Cash Conversion Cycle$364.38$188.96245
Moderate Growth
Days Of Inventory Outstanding321.41340.98375
Moderate Decline
Days Of Sales Outstanding41.2443.41204
High Variability
Free Cash Flow Operating Cash Flow Ratio2.42.281.2635
Moderate Growth
Fixed Asset Turnover1.731.650.5562
Moderate Growth
Debt Ratio1.170.971.2818
Moderate Decline
Price Sales Ratio2.32x2.44x54.9005
Consistent Decline
Asset Turnover0.410.390.1769
Moderate Growth

Valuation Indicators

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap$2.37 billion$3.19 billion2.8 B
Stable
Enterprise Value$3.34 billion$4.22 billion3.7 B
Stable

Core Fundamental Drivers

Forward Price Earnings7.9114
Cash And Short Term Investments172.36 million

Shares Outstanding Driver Correlations

Correlation analysis shows which Alvotech accounts are most structurally linked to Shares Outstanding. The data reflects historical co-movement patterns that help explain how Shares Outstanding responds to underlying financial changes.
Competition

Alvotech Common Stock Shares Outstanding

Common Stock Shares Outstanding

$200.87 million
Common Stock Shares Outstanding stood at 279.19 million as of December 31, 2025.

Alvotech Fundamental Drivers Relationships

Main Technical Indicators as of May 7, 2026

Daily Market Strength Indicators

For investors tracking Alvotech, market strength indicators offer quantitative evaluation of stock behavior. When Rate of Change diverges from price direction, it often signals weakening momentum before a visible reversal in Alvotech.

Basic Forecasting Models

Volume-weighted price analysis for Alvotech Stock gives heavier weight to price levels where trading activity was highest. Crossovers in the MACD line and signal line identify shifts in Alvotech momentum before they appear in raw price.

Alvotech Related Equities

These related stocks within the Health Care space give benchmarks for judging Alvotech's results, margins, and growth trend. Checking Alvotech against peers on P/E, margins, and return on equity helps put its position in context.
 Risk & Return  Correlation

Shares Outstanding Peer Comparison

Peer comparison of Alvotech using Shares Outstanding provides a quantitative benchmark against similar stocks. Identifying gaps in Alvotech's Shares Outstanding relative to peers supports more targeted investment analysis.
Alvotech is currently under evaluation in shares outstanding compared to key competitors.

Important Fundamentals

Financial Metrics, Fundamentals & Methodology

Alvotech's core fundamentals cover profitability, capital efficiency, and funding structure. Capital intensity is provided as a reference for reinvestment requirements. For the latest reporting period, Alvotech reports revenue of 586.32 million, positive EPS of 0.1, operating margin of 33.84%.

Alvotech data is compiled from periodic company reporting and market reference feeds and standardized for comparability. Sell-side coverage, where present, supplements the data shown. Statement-level metrics reflect company-reported GAAP or IFRS formats for the relevant filing period.

Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board